Inventor · disambiguated record
Brian Gavin
Also filed as: GAVIN BRIAN CHARLES · GAVIN BRIAN J
3 granted patents·11 pending applications·86 citations·filing 1982–2003
75Inventor score
Top patents by PatentIndex Score
14 records- 0190USD274115SCoffee filter holderGAVIN BRIAN J·Filed 1982·Granted Jun 5, 1984·42 cites·1 claims
- 0284USD278116SCoffee filter holderGAVIN BRIAN J·Filed 1982·Granted Mar 26, 1985·25 cites·1 claims
- 0377USD318001SCoffee filterGAVIN THOMAS W·Filed 1989·Granted Jul 9, 1991·19 cites·1 claims
- 0444US2004038953A1Medical combination comprising salmeterol and budesonideFiled 2003·Application pending·0 cites
- 0540US2003114537A1Medical combinations comprising mometasone and salmeterolFiled 2001·Application pending·0 cites
- 0640US2004019025A1Medical compositions comprising (r,r)-formoterol and rofleponideFiled 2001·Application pending·0 cites
- 0739US2003125313A1Medical combination comprising salmeterol and budesonideFiled 2001·Application pending·0 cites
- 0836US2005042171A1Pharmaceutical combinations comprising salmeterol and fluticasone proprionate for the treatment of asthmaFiled 2002·Application pending·0 cites
- 0933US2003109510A1Medical combinations comprising formoterol and budesonideFiled 2001·Application pending·0 cites
- 1033US2003119859A1Medical combinations comprising tiotropium and rofleponideFiled 2001·Application pending·0 cites
- 1133US2003119802A1Medical combinations comprising tiotropium and budesonideFiled 2001·Application pending·0 cites
- 1233US2003139383A1Medical combinations comprising tiotropium and mometasoneFiled 2001·Application pending·0 cites
- 1333US2003096874A1Respiratory compositionsFiled 2001·Application pending·0 cites
- 1433US2003113269A1Medical combinations comprising tiotropium and fluticasone proprionateFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Brian Gavin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →